Production (Stage)
Arcadia Biosciences, Inc.
RKDA
$4.28
$0.102.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.20M | 1.22M | 1.54M | 1.31M | 987.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20M | 1.22M | 1.54M | 1.31M | 987.00K |
| Cost of Revenue | 682.00K | 643.00K | 1.05M | 643.00K | 471.00K |
| Gross Profit | 518.00K | 573.00K | 484.00K | 663.00K | 516.00K |
| SG&A Expenses | 1.74M | 2.65M | 2.24M | 2.68M | 2.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.42M | 3.34M | 3.30M | 3.33M | 2.54M |
| Operating Income | -1.22M | -2.13M | -1.76M | -2.02M | -1.55M |
| Income Before Tax | 2.60M | -4.03M | -1.18M | 1.85M | -947.00K |
| Income Tax Expenses | -- | 8.00K | -- | -- | -- |
| Earnings from Continuing Operations | 2.60M | -4.04M | -1.18M | 1.85M | -947.00K |
| Earnings from Discontinued Operations | -- | -27.00K | -430.00K | -789.00K | -1.48M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.60M | -4.06M | -1.61M | 1.06M | -2.42M |
| EBIT | -1.22M | -2.13M | -1.76M | -2.02M | -1.55M |
| EBITDA | -1.21M | -2.10M | -1.75M | -1.99M | -1.50M |
| EPS Basic | 1.90 | -2.98 | -1.18 | 0.78 | -1.78 |
| Normalized Basic EPS | 0.39 | -1.77 | -0.54 | -0.99 | -0.42 |
| EPS Diluted | 1.90 | -2.98 | -1.18 | 0.78 | -1.78 |
| Normalized Diluted EPS | 0.39 | -1.77 | -0.54 | -0.99 | -0.42 |
| Average Basic Shares Outstanding | 1.37M | 1.37M | 1.36M | 1.36M | 1.36M |
| Average Diluted Shares Outstanding | 1.37M | 1.37M | 1.36M | 1.36M | 1.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |